ProtoKinetix Inc (PKTX)

[PK holder]

No news is good news

When you're in a phase 1 trial you will not get updates on every patient that is in the study. This study has to have 10 patients for it to be complete and 90 days after the 10th patient the results will be known. What we don't know is how many patients are currently enrolled. You need a dead person sadly with a healthy pancreas and then a citizen of Alberta who meets the criteria of the study to enroll. What we do know is, since the health Canada website says the study is active and ongoing , there has been no adverse reactions or deaths from the AAGP. Once a reaction occurs the study is stopped and Health Canada is notified and they have to update their website. Since that hasn't happened we can assume the study is going on and we just sit and wait.